Inspire Medical Systems, Inc.

NYSE:INSP

Sector

🏥 Health Care

Industries

💻 Telehealth

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

Location

United States

Market Cap

USD 3.86 B

Share Price

USD 130.91

Avg Daily Volume

490,941

Change (1 day)

0.93%

Change (1 year)

-21.94%

Change (YTD)

-29.38%

Inspire Medical Systems, Inc. Inventory for the year ending December 31, 2024: USD 80.12 M

Inspire Medical Systems, Inc. Inventory is USD 80.12 M for the year ending December 31, 2024, a 136.44% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Inspire Medical Systems, Inc. Inventory for the year ending December 31, 2023 was USD 33.88 M, a 185.08% change year over year.
Inspire Medical Systems, Inc. Inventory for the year ending December 31, 2022 was USD 11.89 M, a -31.02% change year over year.
Inspire Medical Systems, Inc. Inventory for the year ending December 31, 2021 was USD 17.23 M, a 103.22% change year over year.
Inspire Medical Systems, Inc. Inventory for the year ending December 31, 2020 was USD 8.48 M, a 45.34% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Inventory	Current Assets	Property, Plant, Equipment (Net)	Total Assets

NYSE: INSP

Inspire Medical Systems, Inc.

CEO	Mr. Timothy P. Herbert
IPO Date	May 3, 2018
Location	United States
Headquarters	5500 Wayzata Boulevard
Employees	1,246
Sector	🏥 Health Care
Industries Telehealth 🧬 Biotechnology 🔬 Clinical Trials 🩺 Medical Instruments

Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.